approval
saveWEGOVY (SEMAGLUTIDE) — FDA approval
March 19, 2026updated 5mo ago
community read0 votes
Sponsor: NOVO. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalWEGOVY (SEMAGLUTIDE) — FDA approvalMar 19, 2026
- recallHarbin Jixianglong Biotech Co., Ltd. recall (Cls II)Mar 11, 2026
- recallHarbin Jixianglong Biotech Co., Ltd. recall (Cls II)Mar 11, 2026
- approvalWEGOVY (SEMAGLUTIDE) — FDA approvalFeb 25, 2026
- approvalWEGOVY (SEMAGLUTIDE) — FDA approvalFeb 25, 2026
- phase 2 initiationzalfermin: Novo Nordisk AS — zalfermin (Phase II Trial Initiation)Apr 25, 2026
🐶 often sniffed alongside
top 7- companyNovo Nordisk Inc2 co-mentions · 2 sources
- tagHepatology2 co-mentions · 1 sources
- tagObesity2 co-mentions · 1 sources
- tagEndocrinology & Metabolism1 co-mentions · 1 sources
- drugObesity1 co-mentions · 1 sources
- drugzalfermin1 co-mentions · 1 sources
- drugcagrilintide hydrochloride1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that